3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
Conditions
Melanoma
19
Neoplasms
7
Breast Neoplasms
5
Pancreatic Neoplasms
4
Hematologic Neoplasms
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Thyroid Carcinoma, Anaplastic
2
Thyroid Cancer, Papillary
2
Sarcoma
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Gastrointestinal Neoplasms
2
Erdheim-Chester Disease
2
Colorectal Neoplasms
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Thrombocytosis
1
Solid Tumor
1
Skin Neoplasms
1
Sarcoma, Clear Cell
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
fludarabine
3
Tacrolimus
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
thymoglobulin
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Rituximab
2
Mycophenolic Acid
2
Clofarabine
2
Antilymphocyte Serum
2
trametinib
1
etoposide phosphate
1
dabrafenib
1
cobimetinib
1
Thiotepa
1
Specimen Handling
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Filgrastim
1
Etoposide
1
Enzyme-Linked Immunosorbent Assay
1
Deferasirox
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Histiocytosis, Langerhans-Cell
×
cobimetinib
×
Clear all
NCT04079179
2025-09-18
NACHO-COBI
Baylor College of Medicine
Phase 2
Recruiting
90 enrolled